These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12504042)

  • 21. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy.
    Kirakli EK; Erdem S; Susam S; Erim E
    J Cancer Res Ther; 2023; 19(5):1153-1159. PubMed ID: 37787278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.
    Yu JH; Wang CL; Liu Y; Wang JM; Lv CX; Liu J; Zhang Q; Fu XL; Cai XW
    Cancer Radiother; 2021 Jun; 25(4):323-329. PubMed ID: 33446419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
    Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
    Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
    Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM
    Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of dosimetric factors predicting radiation toxicity in lung cancer treatment].
    Letautiene SR; Valuckas KP
    Medicina (Kaunas); 2006; 42(4):314-20. PubMed ID: 16687903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer.
    Asakura H; Hashimoto T; Zenda S; Harada H; Hirakawa K; Mizumoto M; Furutani K; Hironaka S; Fuji H; Murayama S; Boku N; Nishimura T
    Radiother Oncol; 2010 May; 95(2):240-4. PubMed ID: 20223539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
    Ma L; Ye W; Li Q; Wang B; Luo G; Chen Z; Guo S; Qiu B; Liu H
    Clin Lung Cancer; 2018 Mar; 19(2):e211-e217. PubMed ID: 29017827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
    Roach M; Gandara DR; Yuo HS; Swift PS; Kroll S; Shrieve DC; Wara WM; Margolis L; Phillips TL
    J Clin Oncol; 1995 Oct; 13(10):2606-12. PubMed ID: 7595714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.
    Ueyama T; Arimura T; Takumi K; Nakamura F; Higashi R; Ito S; Fukukura Y; Umanodan T; Nakajo M; Koriyama C; Yoshiura T
    Br J Radiol; 2018 Jun; 91(1086):20170453. PubMed ID: 29565649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
    Shintani T; Kishi N; Matsuo Y; Ogura M; Mitsuyoshi T; Araki N; Fujii K; Okumura S; Nakamatsu K; Kishi T; Atsuta T; Sakamoto T; Narabayashi M; Ishida Y; Sakamoto M; Fujishiro S; Katagiri T; Kim YH; Mizowaki T
    Clin Lung Cancer; 2021 Sep; 22(5):401-410. PubMed ID: 33678582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.
    Luna JM; Chao HH; Diffenderfer ES; Valdes G; Chinniah C; Ma G; Cengel KA; Solberg TD; Berman AT; Simone CB
    Radiother Oncol; 2019 Apr; 133():106-112. PubMed ID: 30935565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
    Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
    Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.
    Moreno M; Aristu J; Ramos LI; Arbea L; López-Picazo JM; Cambeiro M; Martínez-Monge R
    Clin Transl Oncol; 2007 Sep; 9(9):596-602. PubMed ID: 17921108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest.
    Lewis GD; Agrusa JE; Teh BS; Gramatges MM; Kothari V; Allen CE; Paulino AC
    Pract Radiat Oncol; 2018; 8(5):e364-e368. PubMed ID: 29730281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
    Amin NP; Miften M; Kavanagh B; Raben D; Camidge DR; Thornton D; Rochford N; Gaspar LE
    J Thorac Oncol; 2011 Sep; 6(9):1553-62. PubMed ID: 21642862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.
    Kimura T; Togami T; Takashima H; Nishiyama Y; Ohkawa M; Nagata Y
    Br J Radiol; 2012 Feb; 85(1010):135-41. PubMed ID: 21385918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
    Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
    Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.